San Francisco, CA, United States of America

Isaac Craig Henderson

This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent. Top assignees: Prothena Therapeutics Limited, Prothena Biosciences Limited. Active years: 2015-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Isaac Craig Henderson. Retrieved from https://idiyas.com/inventor/isaac-craig-henderson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Isaac Craig Henderson

Introduction

Isaac Craig Henderson is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations. With a total of 3 patents to his name, Henderson's work focuses on innovative methods for treating amyloidosis.

Latest Patents

Henderson's latest patents include groundbreaking formulations and methods for the prophylaxis and treatment of amyloidosis. His patents specifically address both AA amyloidosis and AL amyloidosis, showcasing his commitment to advancing medical treatments. These formulations are designed to improve patient outcomes and provide new avenues for therapy.

Career Highlights

Throughout his career, Henderson has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Prothena Therapeutics Limited and Prothena Biosciences Limited. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical science.

Collaborations

Henderson has worked alongside talented professionals such as Patrick Garidel and Pamela Klein. These collaborations have enriched his research and development efforts, leading to innovative solutions in the treatment of amyloidosis.

Conclusion

Isaac Craig Henderson's contributions to biotechnology and his innovative patents reflect his dedication to improving healthcare. His work continues to inspire advancements in the treatment of amyloidosis, making a lasting impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…